SHW vs SRPT · P/E 29, rev $12.46B vs rev $1.13B
Sherwin-Williams Co (SHW) versus Sarepta Therapeutics Inc (SRPT) — a side-by-side from cached financials, not a winner call.
Sherwin-Williams Co (SHW) is a specialty chemicals company listed on US.
Sarepta Therapeutics Inc (SRPT) is a biotechnology company listed on US.
Latest reported SHW revenue for 2026-06-30 was $12.46B. Net income was $1.38B. SHW currently screens at market cap $75.30B and trailing P/E 29.3.
Latest reported SRPT revenue for 2026-06-30 was $1.13B. Net income was $326.1M. Revenue was up 54.9% from 2026-03-31 to 2026-06-30. SRPT currently screens at market cap $2.34B.
SHW currently screens at market cap $75.30B and trailing P/E 29.3. SRPT currently screens at market cap $2.34B.
Not investment advice. Open the SHW and SRPT stock pages for the full models.
Not investment advice.